to purchase a share of common stock for $1.00 for a period of 27 months after closing date. The securities issued are subject to a four-month lock-up period that expires on May 27, 2021.
In February 2021, 460,740 share purchase warrants were exercised into 460,740 shares of our common stock for gross proceeds of $223,810 to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.49 per share. In addition, the Company issued 40,000 shares of common stock pursuant to the exercise of 40,000 RSUs. The fair value of the RSUs in the amount of $46,400 was credited to common stock.
In March 2021, 590,000 share purchase warrants were exercised into 590,000 shares of our common stock for gross proceeds of $295,000, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.50 per share.
In April 2021, 400,000 share purchase warrants were exercised into 400,000 shares of our common stock for gross proceeds of $200,000, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.50 per share.
On April 21, 2021, the Company announced a $10 million equity offering from Ascent Global Logistics, Inc. (“Ascent”). Pursuant to the offering, Ascent subscribed for and purchased 2,000,000 units at a price of $1.29 per unit for gross proceeds of $2,580,000. Each unit is comprised of one share of common stock and one purchase warrant of the Company. Each warrant will entitle the holder thereof to acquire one share of the Company at a price of $1.50 per warrant share until the date which is 60 months following the closing date. Ascent will also subscribe for and purchase 5,537,313 units at a price of $1.34 per unit for gross proceeds of $7,419,999. Each unit is comprised of one share of non-voting Class A Non-Voting Common Stock and one purchase warrant. Each warrant will entitle the holder thereof to acquire one share, and with other terms and conditions identical to the warrant described above. The financing closed on April 29, 2021 and 2,000,000 shares of common stock,
5,537,313 shares of Class A Non-Voting common stock, and 7,537,313 purchase warrants were issued to Ascent.
In May 2021, 172,603 share purchase warrants were exercised into 172,603 shares of our common stock for gross proceeds of $87,196, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.505 per share.
In June 2021, 3,851,535 share purchase warrants were exercised into 3,851,535 shares of our common stock for gross proceeds of $3,511,845, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.91 per share.
In June 2021, 50,000 stock options were exercised into 50,000 shares of our common stock for gross proceeds of
$12,500, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.25 per share.
In July 2021, 357,999 stock options were exercised into 357,999 shares of our common stock for gross proceeds of $89,499.75, to the Company. The weighted-average common share price, at the time of exercise, for the warrants that were exercised was $0.25 per share.
On October 5,, 2021, several investors exercised a total of 248,228 warrants in exchange for $119,149. On October 15, 2021 an additional 293,548 warrants were exercised in exchange for $155,346.
The offers, sales, and issuances of the securities described above were deemed to be exempt from registration under Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions.
There were no underwriters employed in connection with any of the transactions set forth in Item 15.
II-11